Acrivon Therapeutics, Stock Forecast - Market Facilitation Index
| ACRV Stock | 7.87 0.12 1.55% |
Acrivon Stock Forecast is based on your current time horizon.
Acrivon |
| Check Acrivon Therapeutics, Volatility | Backtest Acrivon Therapeutics, | Information Ratio |
Acrivon Therapeutics, Trading Date Momentum
| On October 18 2024 Acrivon Therapeutics, Common was traded for 7.87 at the closing time. The top price for the day was 8.13 and the lowest listed price was 7.58 . There was no trading activity during the period 0.0. Lack of trading volume on October 18, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.02% . |
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
| Compare Acrivon Therapeutics, to competition |
Other Forecasting Options for Acrivon Therapeutics,
For every potential investor in Acrivon, whether a beginner or expert, Acrivon Therapeutics,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Acrivon Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Acrivon. Basic forecasting techniques help filter out the noise by identifying Acrivon Therapeutics,'s price trends.Acrivon Therapeutics, Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acrivon Therapeutics, stock to make a market-neutral strategy. Peer analysis of Acrivon Therapeutics, could also be used in its relative valuation, which is a method of valuing Acrivon Therapeutics, by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Acrivon Therapeutics, Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Acrivon Therapeutics,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Acrivon Therapeutics,'s current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Acrivon Therapeutics, Market Strength Events
Market strength indicators help investors to evaluate how Acrivon Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acrivon Therapeutics, shares will generate the highest return on investment. By undertsting and applying Acrivon Therapeutics, stock market strength indicators, traders can identify Acrivon Therapeutics, Common entry and exit signals to maximize returns.
Acrivon Therapeutics, Risk Indicators
The analysis of Acrivon Therapeutics,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Acrivon Therapeutics,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting acrivon stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.36 | |||
| Semi Deviation | 3.8 | |||
| Standard Deviation | 4.38 | |||
| Variance | 19.18 | |||
| Downside Variance | 15.01 | |||
| Semi Variance | 14.46 | |||
| Expected Short fall | (3.95) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acrivon Stock Analysis
When running Acrivon Therapeutics,'s price analysis, check to measure Acrivon Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics, is operating at the current time. Most of Acrivon Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics,'s price. Additionally, you may evaluate how the addition of Acrivon Therapeutics, to your portfolios can decrease your overall portfolio volatility.